Trial Profile
A Phase II Study of Concurrent Chemoradiotherapy With Weekly Docetaxel and Cisplatin in Inoperable Esophageal Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jul 2012
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 23 Jul 2012 New trial record